DALLAS, April 16 – In the first study of its kind, an implantable cardioverter defibrillator (ICD), a device used to treat heart rhythm abnormalities, was found to be moderately cost-effective for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results